View in EDS

AK5 suppresses breast cancer progression and modulates anti-PD-L1 efficacy via the miR-182-5p/PD-L1 axis.

Saved in:
Bibliographic Details
Title: AK5 suppresses breast cancer progression and modulates anti-PD-L1 efficacy via the miR-182-5p/PD-L1 axis.
Authors: Sun GS; Department of Breast Surgery, The Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Li YH; Department of Breast Surgery, The First Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Li L; Department of Breast Surgery, The Fourth People's Hospital of Zhenjiang, Zhenjiang, Jiangsu, China., Fan LL; Department of Breast Surgery, The Fourth People's Hospital of Zhenjiang, Zhenjiang, Jiangsu, China., Yang H; Department of Breast Surgery, The Fourth People's Hospital of Zhenjiang, Zhenjiang, Jiangsu, China., Lu Q; Department of Breast Surgery, Changzhou Maternity and Child Health Care Hospital, Changzhou, Jiangsu, China., Liu Z; Department of Thyroid and Breast Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China., Wang S; Department of Breast Surgery, The Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China., Peng JJ; Department of Breast Surgery, The First Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Department of Breast Surgery, The Fourth People's Hospital of Zhenjiang, Zhenjiang, Jiangsu, China.
Source: IScience [iScience] 2026 Mar 06; Vol. 29 (4), pp. 115260. Date of Electronic Publication: 2026 Mar 06 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2026.115260